Overview

• Closing is expected in the fourth quarter of 2025, with Privia financing the deal from cash on hand and projecting a positive Adjusted EBITDA contribution in 2026.
• The business includes over 120,000 attributed lives across MSSP, Medicare Advantage and commercial, with analysts estimating 70,000 to 80,000 in MSSP.
• Evolent plans to use proceeds to reduce debt and refocus on its specialty care management offerings.
• Evolent Care Partners is affiliated with more than 1,000 physicians, creating cross-sell opportunities for Privia’s medical groups, technology and services platform.
• Analysts see potential upside from stronger MSSP performance, noting Evolent Care Partners’ 2024 shared-savings rate of 5.9% compared with Privia’s 9.3%.